“Having worked across many operational areas of a large multinational pharmaceutical company including over 20 years deeply focused on clinical development, regulatory strategy and commercial needs of the Asian markets, I’m excited to join Naia’s Business Advisory Board. Naia’s plan to use an efficient operating process, a global strategy to develop drugs incorporating early input from key stakeholders will lead to the development of cost-effective, innovative therapeutic solutions that can address the local and global healthcare needs.”
Dr Jorge Puente MD
Chairman – Naia Board of Advisors
Jorge Puente MD, serves as chairman of Naia’s Board of Business Advisors.
He is a co-founder and managing partner at Pleasanton Pharma Ventures, an investment firm founded in 2014 to invest in late-stage development programs. Prior to his current position, he was regional president, Asia Pacific and Canada, of Pfizer’s Oncology Business Unit responsible for operations in Japan, Australia, New Zealand, Canada and Korea. Prior to that, he held several positions of increasing responsibility at Pfizer including vice president, Medical and Regulatory Affairs, Japan and Asia Region; senior vice president and medical director, Pfizer – Japan; and medical director, Pfizer – China.
Early in his career, Dr. Puente was assistant professor of medicine at Mount Sinai Medical Center in New York, where he won the Solomon Benson Award for excellence in teaching medicine. Dr. Puente is recognized internationally for his humanitarian work. He organized the First World Congress on Post Traumatic Stress Disorder in Thailand after the tsunami in 2004 which resulted in numerous programs to aid those affected. He organized similar programs in Pakistan after the 2005 earthquake. In May 2013, Dr. Puente received “The Spirit of Asian American Award” from the Asian American Federation for his humanitarian work in Asia. Dr. Puente is a National Board Member of the Smithsonian.
Dr. Puente received his M.D. from SUNY Stony Brook and completed his postgraduate training at Mount Sinai Medical Center in New York.